Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
ObesityAdiposity
Interventions
DEVICE

Hybrid Argon Plasma Coagulation (HAPC)

Gastric mucosal ablation is an endoscopic procedure which uses argonplasma coagulation in combination with submucosal injection to achieve selective ablation to the gastric mucosa and preventing thermal damage to the muscle layer.

Trial Locations (2)

27513

True You Weight Loss, Cary

32224

Mayo Clinic, Jacksonville

Sponsors
All Listed Sponsors
collaborator

Erbe USA Incorporated

OTHER

lead

Erbe Elektromedizin GmbH

INDUSTRY

NCT05486338 - Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy | Biotech Hunter | Biotech Hunter